| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |